Photo of Ted Schenkelberg

Ted Schenkelberg, MBA, MPH

COO, Human Immunomics Initiative; Visiting Scientist, Harvard T.H. Chan School of Public Health

Ted Schenkelberg, MBA, MPH, brings more than 15 years of experience applying business management principles to advance biomedical and global health priorities across the nonprofit and for-profit sectors. He is co-founder of the Human Vaccines Project, where he currently serves as chief operating officer.

Previously, Schenkelberg worked as a strategic consultant in the global health and biotech space, including work for a leading Indian health system and national initiatives on reproductive health and antibiotic resistance. He served for more than seven years as a director at the International AIDS Vaccine Initiative (IAVI), where he played a key role in building a $50 million global vaccine design program.

Schenkelberg brings strong private-sector experience, having worked as a licensed health and technology analyst at Carnegie Capital, an investment firm with more than $1 billion under management and administration. He also has served on the board of directors for the African Services Committee in New York City, the largest U.S. organization supporting African immigrants and asylum seekers.

Schenkelberg has an MPH in infectious disease from the Johns Hopkins Bloomberg School of Public Health; an MBA from the University of Chicago Booth School of Business, where he completed joint graduate work at the London School of Economics; and a BA in history (honors) from Grinnell College.

In 2020, Schenkelberg was appointed visiting scientist at the Harvard T.H. Chan School of Public Health.